Medistep Healthcare Limited (NSE:MEDISTEP)
18.20
+0.05 (0.28%)
At close: Nov 13, 2026
Medistep Healthcare Revenue
Medistep Healthcare had revenue of 186.87M INR in the quarter ending September 30, 2026, with 66.09% growth. This brings the company's total for the last twelve months to 731.36M, up 30.74% year-over-year. In the fiscal year ending March 31, 2026, Medistep Healthcare had annual revenue of 708.31M with 42.65% growth. That makes Medistep Healthcare the 38,452nd largest company in the world by revenue and 3,516th in India.
Revenue (ttm)
731.36M
Revenue Growth
+30.74%
P/S Ratio
0.35
Revenue / Employee
121.89M
Employees
6
Market Cap
258.61M
Revenue by Segment
- Trading 552.90M 78.1%
- Manufacturing 155.41M 21.9%
Fiscal year ended Mar 31, 2026 See the full Medistep Healthcare breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 708.31M | 211.76M | 42.65% |
| Mar 31, 2025 | 496.55M | 105.83M | 27.09% |
| Mar 31, 2024 | 390.72M | 114.25M | 41.33% |
| Mar 31, 2023 | 276.47M | 200.22M | 262.61% |
| Mar 31, 2022 | 76.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Chandra Bhagat Pharma | 1.74B |
| Dipna Pharmachem | 1.31B |
| VijayPD Ceutical | 1.00B |
| Medico Intercontinental | 864.77M |
| Zenlabs Ethica | 485.60M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |